↓ Skip to main content

Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials

Overview of attention for article published in Breast Cancer Research and Treatment, September 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
15 X users
patent
1 patent

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
60 Mendeley